Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / bristol myers 2seventy bio receive fda approval for

BMY - Bristol Myers 2seventy bio receive FDA approval for Abecma to treat multiple myeloma

Bristol-Myers Squibb Company

2024-04-05 09:33:47 ET

Bristol Myers Squibb ( NYSE: BMY ) said on Friday that the company and 2seventy bio ( NASDAQ: TSVT ) received U.S. FDA approval for Abecma in the treatment of adult patients with relapsed or refractory multiple myeloma....

For further details see:

Bristol Myers, 2seventy bio receive FDA approval for Abecma to treat multiple myeloma
Stock Information
Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Website: bms.com
Menu
BMY BMY Quote BMY Short BMY News BMY Articles BMY Message Board
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...